{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:51:45Z","timestamp":1792439505780,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7325","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nature09586","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T13:19:19Z","timestamp":1288963159000},"page":"839-843","source":"Crossref","is-referenced-by-count":1205,"title":["Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2"],"prefix":"10.1038","volume":"468","author":[{"given":"Myunggon","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utz J.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Tahiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hozefa S.","family":"Bandukwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungeun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Lamperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Peng","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ganetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Shirley","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Aravind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneet","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"key":"BFnature09586_CR1","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009)","journal-title":"Science"},{"key":"BFnature09586_CR2","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.4161\/cc.8.11.8580","volume":"8","author":"LM Iyer","year":"2009","unstructured":"Iyer, L. M., Tahiliani, M., Rao, A. & Aravind, L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 8, 1698\u20131710 (2009)","journal-title":"Cell Cycle"},{"key":"BFnature09586_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/sj.leu.2403818","volume":"19","author":"F Vigui\u00e9","year":"2005","unstructured":"Vigui\u00e9, F. et al. Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement? Leukemia 19, 1411\u20131415 (2005)","journal-title":"Leukemia"},{"key":"BFnature09586_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","volume":"114","author":"O Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab, O. et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114, 144\u2013147 (2009)","journal-title":"Blood"},{"key":"BFnature09586_CR5","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F. et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360, 2289\u20132301 (2009)","journal-title":"N. Engl. J. Med."},{"key":"BFnature09586_CR6","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","volume":"113","author":"AM Jankowska","year":"2009","unstructured":"Jankowska, A. M. et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms. Blood 113, 6403\u20136410 (2009)","journal-title":"Blood"},{"key":"BFnature09586_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SM Langemeijer","year":"2009","unstructured":"Langemeijer, S. M. et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nature Genet. 41, 838\u2013842 (2009)","journal-title":"Nature Genet."},{"key":"BFnature09586_CR8","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMe0902257","volume":"360","author":"RL Levine","year":"2009","unstructured":"Levine, R. L. & Carroll, M. A common genetic mechanism in malignant bone marrow diseases. N. Engl. J. Med. 360, 2355\u20132357 (2009)","journal-title":"N. Engl. J. Med."},{"key":"BFnature09586_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ng0709-766","volume":"41","author":"CG Mullighan","year":"2009","unstructured":"Mullighan, C. G. TET2 mutations in myelodysplasia and myeloid malignancies. Nature Genet. 41, 766\u2013767 (2009)","journal-title":"Nature Genet."},{"key":"BFnature09586_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/leu.2009.37","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi, A. et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia 23, 900\u2013904 (2009)","journal-title":"Leukemia"},{"key":"BFnature09586_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/leu.2009.59","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi, A. et al. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS\/MPN and AML. Leukemia 23, 1343\u20131345 (2009)","journal-title":"Leukemia"},{"key":"BFnature09586_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/leu.2009.47","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi, A. et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 23, 905\u2013911 (2009)","journal-title":"Leukemia"},{"key":"BFnature09586_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129\u20131133 (2010)","journal-title":"Nature"},{"key":"BFnature09586_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1021\/bi00571a013","volume":"18","author":"H Hayatsu","year":"1979","unstructured":"Hayatsu, H. & Shiragami, M. Reaction of bisulfite with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. Biochemistry 18, 632\u2013637 (1979)","journal-title":"Biochemistry"},{"key":"BFnature09586_CR15","doi-asserted-by":"publisher","first-page":"e8888","DOI":"10.1371\/journal.pone.0008888","volume":"5","author":"Y Huang","year":"2010","unstructured":"Huang, Y. et al. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS ONE 5, e8888 (2010)","journal-title":"PLoS ONE"},{"key":"BFnature09586_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315\u2013322 (2009)","journal-title":"Nature"},{"key":"BFnature09586_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1080\/10428190802578866","volume":"49","author":"A Tefferi","year":"2008","unstructured":"Tefferi, A. Epigenetic alterations and anti-epigenetic therapy in myelofibrosis. Leuk. Lymphoma 49, 2231\u20132232 (2008)","journal-title":"Leuk. Lymphoma"},{"key":"BFnature09586_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.tig.2007.07.005","volume":"23","author":"LT Smith","year":"2007","unstructured":"Smith, L. T., Otterson, G. A. & Plass, C. Unraveling the epigenetic code of cancer for therapy. Trends Genet. 23, 449\u2013456 (2007)","journal-title":"Trends Genet."},{"key":"BFnature09586_CR19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller, M. Epigenetics in cancer. N. Engl. J. Med. 358, 1148\u20131159 (2008)","journal-title":"N. Engl. J. Med."},{"key":"BFnature09586_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.med.59.061606.095816","volume":"59","author":"EN Gal-Yam","year":"2008","unstructured":"Gal-Yam, E. N., Saito, Y., Egger, G. & Jones, P. A. Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med. 59, 267\u2013280 (2008)","journal-title":"Annu. Rev. Med."},{"key":"BFnature09586_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/epi.09.33","volume":"1","author":"M Ehrlich","year":"2009","unstructured":"Ehrlich, M. DNA hypomethylation in cancer cells. Epigenomics 1, 239\u2013259 (2009)","journal-title":"Epigenomics"},{"key":"BFnature09586_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.1084468","volume":"300","author":"C Lengauer","year":"2003","unstructured":"Lengauer, C. Cancer. An unstable liaison. Science 300, 442\u2013443 (2003)","journal-title":"Science"},{"key":"BFnature09586_CR23","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ng.463","volume":"41","author":"A-M Br\u00f6ske","year":"2009","unstructured":"Br\u00f6ske, A.-M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nature Genet. 41, 1207\u20131215 (2009)","journal-title":"Nature Genet."},{"key":"BFnature09586_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1083558","volume":"300","author":"F Gaudet","year":"2003","unstructured":"Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489\u2013492 (2003)","journal-title":"Science"},{"key":"BFnature09586_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/2413","volume":"20","author":"CP Walsh","year":"1998","unstructured":"Walsh, C. P., Chaillet, J. R. & Bestor, T. H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nature Genet. 20, 116\u2013117 (1998)","journal-title":"Nature Genet."},{"key":"BFnature09586_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","volume":"113","author":"Y Jiang","year":"2009","unstructured":"Jiang, Y. et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 113, 1315\u20131325 (2009)","journal-title":"Blood"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature09586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature09586","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature09586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:48:38Z","timestamp":1684417718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature09586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":26,"journal-issue":{"issue":"7325","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnature09586"],"URL":"https:\/\/doi.org\/10.1038\/nature09586","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7157956.8000058","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.7157956.7390054","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}